Home › Funds › Avoro Capital Advisors LLC › KRYS

Avoro Capital Advisors LLC position in KRYS

KRYSTAL BIOTECH INC · Health Care

Avoro Capital Advisors LLC reported holding 2,888,888 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$960.7M, representing 9.94% of its reported portfolio and ranking #3 among its reported holdings. Avoro Capital Advisors LLC has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.89M sh
Reported value held$960.73M
Portfolio Weight9.94%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Avoro Capital Advisors LLC's KRYS position evolved

Avoro Capital Advisors LLC first disclosed a stake in KRYS in Q3 2023 at 2,565,555 shares (US$297.6M). The position peaked in Q2 2026 at 2,888,888 shares, worth US$1.07B. Across 13 filings, Avoro Capital Advisors LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,888,888 shares valued at US$960.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.57M $297.60M New
Q4 2023 2.57M $318.28M Hold
Q1 2024 2.56M $454.71M Hold
Q2 2024 2.43M $446.80M Reduce
Q3 2024 2.62M $477.32M Add
Q4 2024 2.63M $411.83M Hold
Q1 2025 2.73M $492.40M Add
Q2 2025 2.66M $365.64M Reduce
Q3 2025 2.78M $490.36M Add
Q4 2025 2.89M $712.23M Add
Q1 2026 2.89M $746.26M Hold
Q2 2026 2.89M $1.07B Hold
Q3 2026 2.89M $960.73M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 41 other funds we track also report a position in KRYS — the largest reported positions include Soleus Capital Management, L.P. (US$349.1M), Redmile Group, LLC (US$234.9M), Hood River Capital Management LLC (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has Avoro Capital Advisors LLC held KRYS?

Avoro Capital Advisors LLC has disclosed KRYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Avoro Capital Advisors LLC's current position in KRYS?

As of Q3 2026, Avoro Capital Advisors LLC holds 2.89M shares of KRYS (KRYSTAL BIOTECH INC), valued at $960.73M, representing 9.94% of its reported portfolio and ranking #3.

Has Avoro Capital Advisors LLC been buying or selling KRYS?

In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC held unchanged its position in KRYS. The position peaked in Q2 2026 at 2.89M shares.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Soleus Capital Management, L.P., Redmile Group, LLC, Hood River Capital Management LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.